Illumina collaborates with 54gene in the creation of a world-class genomics facility in Nigeria

Originally published at: Illumina collaborates with 54gene in the creation of a world-class genomics facility in Nigeria

Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. The partnership will support the establishment of a new genetics facility in Lagos, Nigeria, equipped with a suite of Illumina’s cutting-edge sequencing and high-density…